Edwards Lifesciences
EW
Delayed Nyse - 11/22 10:01:48 pm
108.81USD
-0.65%
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Advanced Medical Equipment & Technology
   Advanced Medical Equipment & Technology - NEC
Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease.

It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.

Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care.

The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve.

The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass.

The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques.

The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems.

The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts.

The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Number of employees : 11 100 persons.
Sales per Businesses
20152016
USD
(in Million)
%USD
(in Million)
%
Transcatheter Heart Valve Therapy1,18047.3%1,62954.9%
Surgical Heart Valve Therapy785.0031.5%774.9026.1%
Critical Care528.4021.2%560.3018.9%
Sales per Regions
20152016
USD
(in Million)
%USD
(in Million)
%
United States1,26350.6%1,61654.5%
Europe717.3028.8%749.0025.3%
Rest of World267.3010.7%289.709.8%
Japan246.209.9%309.3010.4%
Managers
- Chairman & Chief Executive Officer :
    Michael Mussallem
- Chief Financial Officer & Vice President :
    Scott Ullem
- Chief Scientific Officer & VP-Advanced Technology :
    Stanton Rowe
- Independent Director :
    John Cardis
- Independent Director :
    William Link
- Independent Director :
    Wesley von Schack
- Independent Director :
    Nicholas Valeriani
- Independent Director :
    Kieran Gallahue
- Independent Director :
    Martha Marsh
- Independent Director :
    Steven Loranger
Company contact information
Edwards Lifesciences Corp.
One Edwards Way
Irvine, CA 92614

Phone : +1.949.250.2500
Fax : +1.949.250.2525
Web : www.edwards.com
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision